Why Viking Therapeutics could make a splash Viking Therapeutics' leading weight-loss candidate, VK2735, is a GLP-1 medicine being developed in both oral and subcutaneous formulations
The findings come as manufacturers like Novo Nordisk and Eli Lilly face dozens of lawsuits from patients who have suffered stomach paralysis, diarrhea, and suicidal thoughts after taking weight loss drugs
Buzz kill: Virginia Tech researchers find drugs used to treat Type 2 diabetes reduce alcohol cravings, use in individuals with obesity Fralin Biomedical Research Institute study analyzed social media posts and self-reported experiences among patients who use drugs such as Ozempic, Wegovy, and Mounjaro In social media posts on the community network Reddit, users reported reduced cravings for alcohol when taking drugs intended to treat Type 2 diabetes and obesity
The results show a community in distress
Common semaglutide side effects (nausea, vomiting, constipation) and bupropion effects (dry mouth, insomnia, mild blood pressure elevation) may overlap or feel amplified early in treatment
Sourcing and Storing Semaglutide Safely As semaglutides popularity has grown, so has the market for counterfeit and unapproved versions
